 |
|
 |
Companies (Medical Device) |
|
|
Mentor Medical Device Company Intelligence Report
Publication Date July 2006
Publisher Espicom
Product Type Report
Pages 42
ISBN Number not applicable
Product Code ESP502
|
|
|
Summary
Mentor Corporation, headquartered in Santa Barbara, California, USA, develops, manufactures and markets products for plastic and reconstructive surgery. Until recently, Mentor also had a strong position in the urology market but, in June 2006, sold its Surgical Urology and Clinical and Consumer Healthcare units to Coloplast, leaving it with only the Aesthetic and General Surgery segment.
Mentor's remaining products principally consist of breast implants, tissue expanders, products for traditional liposuction, dermal fillers, cosmetic surgery software and ultrasound-assisted products for soft tissue aspiration in general and cosmetic applications. Most of the products are manufactured and marketed by Mentor, while the company's Byron Medical division offers the liposuction and ultrasound-assisted devices.
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.
|
Content
- Executive Summary
- Overview
- Operating Results
- Fig 1: Total Revenue, 1995-2006 (US$ million)
- Operating Results by Business Segment, 2004-2006 (US$ million)*
- Fig 2: Percentage of Revenue by Business Segment, 2006*
- Recent Key Events
- Strategic Focus
- Product Portfolio And R&d
- Aesthetic and General Surgery Sales by Product Type, 2004-2006 (US$ million)*
- Fig 3: Percentage of Aesthetic and General Surgery Sales by Product, 2006
- New Product Approvals, 2005-2006
- Top 5 Cosmetic Surgery Procedures, 2005*
- Top 5 Non-Surgical Cosmetic Procedures, 2005*
- Facial Aesthetics
- Fig 4: US Dermal Filler Market, 2002-2008E (US$ million)
- Puragen and Puragen Plus
- Breast Implants
- Silicone Gel Implants
- Contour Profile Gel Implants
- US Clinical Trials
- Memory Gel Round Silicone Gel Breast Implant Trial
- Contour Profile Implant Trial
- National Cancer Institute Study
- Saline Breast Implants
- Moderate Plus Profile
- Shaped Implants
- Round Implants
- Becker Adjustable Breast Implants/Expanders
- Spectrum Adjustable Breast Implants
- Tissue Expanders
- Post-Surgical Garments
- BODY CONTOURING AND LIPOSUCTION DEVICES
- ActiPatch
- Ultrasonic Systems
- Aspirators and Accessories
- Infiltration
- Cannulae and Dissectors
- Foam, Tape and Cold Therapy Products
- Alpha Infusion Pumps
- Bleph Instrumentation
- Eye Shields and Splints
- Plastic Surgery Software Solutions
- Inform&Enhance Software
- Insched
- Inform&Consent
- MD Tracker
- ControlRoom
- Research And Development
- Research Establishments
- Research Projects
- Botulinum Toxin
- International Activities
- Revenue from Continuing Operations by Region, 2004-2006 (US$ million)*
- Long-lived Assets from Continuing Operations by Region, 2004-2006 (US$ million)*
- Fig 5: Percentage of Revenue from Continuing Operations by Region, 2006*
- Fig 6: Long-lived Assets from Continuing Operations by Region, 2006*
- Fig 7: Revenue from Continuing Operations by Region, 2004-2006 (US$ million)
- Fig 8: Long-lived Assets from Continuing Operations by Region, 2004-2006 (US$ million)
- North America
- Other Countries
- The Netherlands
- United Kingdom
- Global Manufacturing Facilities
- Appendices
- Appendix 1 - Financial Indicators
- Financial Indicators
- Appendix 2 - Key Corporate Events
- Appendix 3 - Mergers And Acquisitions
- Key Mergers & Acquisitions
- Inform Solutions
- AMI's Uterine Disorder Products
- A-Life
- Rights to ObTape
- Mills Biopharmaceuticals
- Portex's Urology and Ostomy Business
- Byron Medical
- ProSurg Stress Incontinence Product
- Porgs
- DesChutes Medical Products' Pessary Line
- South Bay Medical
- Sierra Laboratories
- Needles & Infusion Technologies' Product Line
- Boston Pacific Medical Devices
- Teknar
- Mentor O&O
- Appendix 4 - Divestitures
- Surgical Urology and Clinical and Consumer Healthcare Divisions
- UK Urisheath Business and US Manufacturing Assets
- North American Scientific
- Ophthalmics Phaco Cataract Removal Business
- Ophthalmology Division - Certain Assets
- Intraocular Lens Business
- Appendix 5 - Agreements
- Key Agreements
- Tutogen Medical
- Coloplast
- Niadyne
- BioElectronics
- Wisconsin Alumni Research Foundation (WARF)
- Misonix
- Appendix 6 - Litigation
- PTF Royalty Partnership
- Operating Results by Business Segment, 2004-2006 (US$ million)*
- Recent Key Events
- Aesthetic and General Surgery Sales by Product Type, 2004-2006 (US$ million)*
- New Product Approvals, 2005-2006
- Top 5 Cosmetic Surgery Procedures, 2005*
- Top 5 Non-Surgical Cosmetic Procedures, 2005*
- Revenue from Continuing Operations by Region, 2004-2006 (US$ million)*
- Long-lived Assets from Continuing Operations by Region, 2004-2006 (US$ million)*
- Global Manufacturing Facilities
- Financial Indicators
- Key Mergers & Acquisitions
- Key Agreements
- Fig 1: Total Revenue, 1995-2006 (US$ million)
- Fig 2: Percentage of Revenue by Business Segment, 2006*
- Fig 3: Percentage of Aesthetic and General Surgery Sales by Product, 2006
- Fig 4: US Dermal Filler Market, 2002-2008E (US$ million)
- Fig 5: Percentage of Revenue from Continuing Operations by Region, 2006*
- Fig 6: Long-lived Assets from Continuing Operations by Region, 2006*
- Fig 7: Revenue from Continuing Operations by Region, 2004-2006 (US$ million)
- Fig 8: Long-lived Assets from Continuing Operations by Region, 2004-2006 (US$ million)
|
|
|
